Early treatment of recurrent superficial bladder tumors before endocavitary prophylaxis: local and sistemic safety and tolerability evaluation

被引：0
|
作者：
Di Cello, V [1 ]
Castigli, M [1 ]
Mondaini, N [1 ]
Maleci, M [1 ]
Gazzarrini, O [1 ]
Dominici, A [1 ]
机构：
[1] Univ Florence, Dept Urol, Florence, Italy
来源：
6TH CONGRESS OF THE MEDITERRANEAN UROLOGICAL ASSOCIATION | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In this study we evaluted local and sistemic safety and tollerability of prophylaxis with Farmorubicina, in 96 patients underwent TUR for solitary recurrent bladder tumor, 0-6 hours since TUR. Our experiencedemostrated no evidence of local or systemic effects during or immediately after treatment. A long term follow-up is necessary to evaluate its efficacy comparing the results obtained in the groups of patients treated with subsequent therapies.
引用
收藏
页码：105 / 108
页数：4
相关论文
共 21 条
123